181 related articles for article (PubMed ID: 19999399)
1. Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
Jouret F; Col V
Acta Clin Belg; 2009; 64(5):457. PubMed ID: 19999399
[No Abstract] [Full Text] [Related]
2. Cabergoline-induced pneumocephalus in a medically treated macroprolactinoma.
Machicado JD; Varghese JM; Orlander PR
J Clin Endocrinol Metab; 2012 Oct; 97(10):3412-3. PubMed ID: 22802088
[No Abstract] [Full Text] [Related]
3. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
Castro-Castro J; Torre-Eiriz JA; Pinzón-Millán A; Pastor-Zapata A
Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
[TBL] [Abstract][Full Text] [Related]
4. The cabergoline-resistant prolactinoma patient: new challenges.
Molitch ME
J Clin Endocrinol Metab; 2008 Dec; 93(12):4643-5. PubMed ID: 19056842
[No Abstract] [Full Text] [Related]
5. Cabergoline treatment of pregnant women with macroprolactinomas.
Laloi-Michelin M; Ciraru-Vigneron N; Meas T
Int J Gynaecol Obstet; 2007 Oct; 99(1):61-2. PubMed ID: 17602689
[No Abstract] [Full Text] [Related]
6. Pituitary apoplexy associated with cabergoline therapy.
Chng E; Dalan R
J Clin Neurosci; 2013 Dec; 20(12):1637-43. PubMed ID: 24113159
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of cabergoline in the treatment of macroprolactinoma].
Dupuy O; Le Marec E; Mayaudon H; Rilminger H; Bordier L; Bauduceau B
Presse Med; 2003 Jan; 32(2):71-2. PubMed ID: 12653031
[No Abstract] [Full Text] [Related]
8. Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.
Cawood TJ; Bridgman P; Hunter L; Cole D
Intern Med J; 2009 Apr; 39(4):266-7. PubMed ID: 19402868
[No Abstract] [Full Text] [Related]
9. Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related macroprolactinoma.
Nanba K; Usui T; Nakakuki T; Shimatsu A
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23749864
[No Abstract] [Full Text] [Related]
10. Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma.
Kars M; Delgado V; Holman ER; Feelders RA; Smit JW; Romijn JA; Bax JJ; Pereira AM
J Clin Endocrinol Metab; 2008 Sep; 93(9):3348-56. PubMed ID: 18559921
[TBL] [Abstract][Full Text] [Related]
11. [Prolactinoma and pregnancy].
Trifonov I
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():16-22. PubMed ID: 15518268
[No Abstract] [Full Text] [Related]
12. Topiramate Overcoming Dopamine Agonist-Induced Migraine Exacerbation and Avoiding Transsphenoidal Surgery in a Young Boy With a Macroprolactinoma.
Faria AM; de F Presti P; Damiani D; Musolino NR; Neto MB
Headache; 2016 Oct; 56(9):1507-1511. PubMed ID: 27400437
[No Abstract] [Full Text] [Related]
13. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.
Raverot G; Jacob M; Jouanneau E; Delemer B; Vighetto A; Pugeat M; Borson-Chazot F
Clin Endocrinol (Oxf); 2009 Apr; 70(4):588-92. PubMed ID: 18673461
[TBL] [Abstract][Full Text] [Related]
14. Cabergoline treatment in a case of macroprolactinoma after delivery.
Falsetti L
Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
[TBL] [Abstract][Full Text] [Related]
15. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
Dhanwal DK; Sharma AK
Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
[TBL] [Abstract][Full Text] [Related]
16. Effect of cabergoline on thyroid function in hyperprolactinaemia.
Keogh MA; Wittert GA
Clin Endocrinol (Oxf); 2002 Nov; 57(5):699. PubMed ID: 12390347
[No Abstract] [Full Text] [Related]
17. The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
Howell DL; Wasilewski K; Mazewski CM; Hudgins RJ; Meacham LR
J Pediatr Hematol Oncol; 2005 Jun; 27(6):326-9. PubMed ID: 15956887
[TBL] [Abstract][Full Text] [Related]
18. Cabergoline use for pituitary tumors and valvular disorders.
Auriemma RS; Pivonello R; Ferreri L; Priscitelli P; Colao A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):89-97. PubMed ID: 25732645
[TBL] [Abstract][Full Text] [Related]
19. Cabergoline and quinagolide therapy for prolactinomas.
Webster J
Clin Endocrinol (Oxf); 2000 Nov; 53(5):549-50. PubMed ID: 11106914
[No Abstract] [Full Text] [Related]
20. Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia.
Miki N
Intern Med; 2001 Sep; 40(9):845-6. PubMed ID: 11579939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
